Advertisement

Diabetic Retinopathy

  • Thomas H. Williamson
Chapter
First Online:
  • 1.4k Downloads

Abstract

There are a number of conditions which stimulate neovascularisation of the retina with subsequent complications such as vitreous haemorrhage and tractional retinal detachment from pathological separation of the vitreous. The most common is severe diabetic retinopathy but also retinal vein occlusion, sickle-cell retinopathy and retinal vasculitis.

Keywords

Diabetic Retinopathy Retinal Detachment Macular Hole Retinal Vein Occlusion Vitreous Haemorrhage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Supplementary material

haemorrhage and trd (426,060 KB)

References

  1. Aaberg TM (1979) Clinical results in vitrectomy for diabetic traction retinal detachment. Am J Ophthalmol 88(2):246–253PubMedGoogle Scholar
  2. Abrams GW, Williams GA (1987) “En bloc” excision of diabetic membranes. Am J Ophthalmol 103(3 Pt 1):302–308PubMedGoogle Scholar
  3. Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R (2009) Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology 116(10):1943–1948. doi: S0161-6420(09)00744-1, [pii]  10.1016/j.ophtha.2009.07.001 PubMedCrossRefGoogle Scholar
  4. Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L, Eid Farah M, Pieramici DJ, Berrocal MH, Sanchez JG (2008) Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 92(2):213–216. doi: bjo.2007.127142, [pii]  10.1136/bjo.2007.127142 avastin 1PubMedCrossRefGoogle Scholar
  5. Barzideh N, Johnson TM (2007) Subfoveal fluid resolves slowly after pars plana vitrectomy for tractional retinal detachment secondary to proliferative diabetic retinopathy. Retina 27(6):740–743. doi: 10.1097/IAE.0b013e318030c663, 00006982-200707000-00011 [pii]PubMedCrossRefGoogle Scholar
  6. Blankenship GW (1980) The lens influence on diabetic vitrectomy results. Report of a prospective randomized study. Arch Ophthalmol 98(12):2196–2198PubMedCrossRefGoogle Scholar
  7. Brown GC, Tasman WS, Benson WE, McNamara JA, Eagle RC Jr (1992) Reoperation following diabetic vitrectomy. Arch Ophthalmol 110(4):506–510PubMedCrossRefGoogle Scholar
  8. Carter JB, Michels RG, Glaser BM, de Bustros S (1990) Iatrogenic retinal breaks complicating pars plana vitrectomy. Ophthalmology 97(7):848–853PubMedGoogle Scholar
  9. Castellarin A, Grigorian R, Bhagat N, Del Priore L, Zarbin MA (2003) Vitrectomy with silicone oil infusion in severe diabetic retinopathy. Br J Ophthalmol 87(3):318–321PubMedCrossRefGoogle Scholar
  10. Celebi S, Kukner AS (2001) Photodisruptive Nd:YAG laser in the management of premacular subhyaloid hemorrhage. Eur J Ophthalmol 11(3):281–286PubMedGoogle Scholar
  11. Chen E, Park CH (2006) Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina 26(6):699–700. doi: 10.1097/01.iae.0000225351.87205.69, 00006982-200607000-00020 [pii]PubMedCrossRefGoogle Scholar
  12. Chu TG, Lopez PF, Cano MR, Freeman WR, Lean JS, Liggett PE, Thomas EL, Green RL (1996) Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmology 103(2):315–322PubMedGoogle Scholar
  13. de Juan E Jr, Hardy M, Hatchell DL, Hatchell MC (1986) The effect of intraocular silicone oil on anterior chamber oxygen pressure in cats. Arch Ophthalmol 104(7):1063–1064PubMedCrossRefGoogle Scholar
  14. Diabetic Retinopathy rsVitrectomy Study Group (1990) Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: diabetic retinopathy vitrectomy study report 5. ArchOphthalmol 108(7):958–964Google Scholar
  15. Diabetic Retinopathy Vitrectomy Study Group (1985) Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management Diabetic Retinopathy Vitrectomy Study (DRVS) report #1. Ophthalmology 92(4):492–502Google Scholar
  16. Early Treatment Diabetic Retinopathy Study Research Group (1991) Early photocoagulation for diabetic retinopathy ETDRS report number 9. Ophthalmology 98(5 Suppl):766–785Google Scholar
  17. Flynn HW Jr, Chew EY, Simons BD, Barton FB, Remaley NA, Ferris FL III (1992) Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 99(9):1351–1357PubMedGoogle Scholar
  18. Gandhi JS, Tan LT, Pearce I, Charles SJ (2008) Bevacizumab (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease. Eye. doi: eye200899, [pii]  10.1038/eye.2008.99
  19. Genovesi-Ebert F, Rizzo S, Chiellini S, Di bartolo E, Marabotti A, Nardi M (1998) Reliability of standardized echography before vitreoretinal surgery for proliferative diabetic retinopathy. Ophthalmologica 212(Suppl 1):91–92PubMedGoogle Scholar
  20. Ghoraba H (2002) Types of macular holes encountered during diabetic vitrectomy. Retina 22(2):176–182PubMedCrossRefGoogle Scholar
  21. Gollamudi SR, Smiddy WE, Schachat AP, Michels RG, Vitale S (1991) Long-term survival rate after vitreous surgery for complications of diabetic retinopathy. Ophthalmology 98(1):18–22PubMedGoogle Scholar
  22. Gonvers M (1990) Temporary silicone oil tamponade in the treatment of complicated diabetic retinal detachments. Graefes Arch Clin Exp Ophthalmol 228(5):415–422PubMedCrossRefGoogle Scholar
  23. Gupta B, Wong R, Sivaprasad S, Williamson TH (2012) Surgical and visual outcome following 20-gauge vitrectomy in proliferative ­diabetic retinopathy over a 10-year period, evidence for change in practice. Eye (Lond). doi: eye2011348, [pii]  10.1038/eye.2011.348
  24. Han DP, Murphy ML, Mieler WF (1994) A modified en bloc excision technique during vitrectomy for diabetic traction retinal detachment. Results and complications. Ophthalmology 101(5):803–808PubMedGoogle Scholar
  25. Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut ­posterior hyaloid membrane. Am J Ophthalmol 121(4):405–413PubMedGoogle Scholar
  26. Heimann K, Dahl B, Dimopoulos S, Lemmen KD (1989) Pars plana vitrectomy and silicone oil injection in proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 227(2):152–156PubMedCrossRefGoogle Scholar
  27. Helbig H, Kellner U, Bornfeld N, Foerster MH (1996) Life expectancy of diabetic patients undergoing vitreous surgery. Br J Ophthalmol 80(7):640–643PubMedCrossRefGoogle Scholar
  28. Helbig H, Kellner U, Bornfeld N, Foerster MH (1998) Rubeosis iridis after vitrectomy for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 236(10):730–733PubMedCrossRefGoogle Scholar
  29. Hershberger VS, Augsburger JJ, Hutchins RK, Raymond LA, Krug S (2004) Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings. Ophthalmology 111(6):1215–1221PubMedCrossRefGoogle Scholar
  30. Holekamp NM, Shui YB, Beebe D (2006) Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract. Am J Ophthalmol 141(6):1027–1032PubMedCrossRefGoogle Scholar
  31. Huang YH, Yeh PT, Chen MS, Yang CH, Yang CM (2009) Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage. Retina 29(8):1134–1140. doi: 10.1097/IAE.0b013e3181b094b7 PubMedCrossRefGoogle Scholar
  32. Ikeda T, Sato K, Katano T, Hayashi Y (1999a) Attached posterior hyaloid membrane and the pathogenesis of honeycombed cystoid macular edema in patients with diabetes. Am J Ophthalmol 127(4):478–479PubMedCrossRefGoogle Scholar
  33. Ikeda T, Sato K, Katano T, Hayashi Y (1999b) Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol 83(1):12–14PubMedCrossRefGoogle Scholar
  34. Imamura Y, Minami M, Ueki M, Satoh B, Ikeda T (2003) Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy. Br J Ophthalmol 87(5):563–566PubMedCrossRefGoogle Scholar
  35. Ishikawa K, Honda S, Tsukahara Y, Negi A (2007) Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy. Eye. doi: 6702983, [pii]  10.1038/sj.eye.6702983
  36. Joondeph BC, Blankenship GW (1989) Hemostatic effects of air versus fluid in diabetic vitrectomy. Ophthalmology 96(12):1701–1706PubMedGoogle Scholar
  37. Kadonosono K, Matsumoto S, Uchio E, Sugita M, Akura J, Ohno S (2001) Iris neovascularization after vitrectomy combined with phacoemulsification and intraocular lens implantation for proliferative diabetic retinopathy. Ophthalmic Surg Lasers 32(1):19–24PubMedGoogle Scholar
  38. Kakehashi A (2002) Total en bloc excision: a modified vitrectomy ­technique for proliferative diabetic retinopathy. Am J Ophthalmol 134(5):763–765PubMedCrossRefGoogle Scholar
  39. Karel I, Kalvodova B (1994) Long-term results of pars plana vitrectomy and silicone oil for complications of diabetic retinopathy. Eur J Ophthalmol 4(1):52–58PubMedGoogle Scholar
  40. Koutsandrea CN, Apostolopoulos MN, Chatzoulis DZ, Parikakis EA, Theodossiadis GP (2001) Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage. Acta Ophthalmol Scand 79(1):34–38PubMedCrossRefGoogle Scholar
  41. Kroll P, Wiegand W, Schmidt J (1999) Vitreopapillary traction in proliferative diabetic vitreoretinopathy [see comments]. Br J Ophthalmol 83(3):261–264PubMedCrossRefGoogle Scholar
  42. Kuhn F, Kiss G, Mester V, Szijarto Z, Kovacs B (2004) Vitrectomy with internal limiting membrane removal for clinically significant macular oedema. Graefes Arch Clin Exp Ophthalmol 242:402–408PubMedCrossRefGoogle Scholar
  43. La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ (2001) Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 239(4):264–270PubMedCrossRefGoogle Scholar
  44. La Heij EC, Tecim S, Kessels AG, Liem AT, Japing WJ, Hendrikse F (2004) Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment. Graefes Arch Clin Exp Ophthalmol 242(3):210–217PubMedCrossRefGoogle Scholar
  45. Laatikainen L, Summanen P, Immonen I (1987) Effect of tranexamic acid on postvitrectomy haemorrhage in diabetic patients. IntOphthalmol 10(3):153–155Google Scholar
  46. Laidlaw DA (2008) Vitrectomy for diabetic macular oedema. Eye 22(10):1337–1341. doi: eye200884, [pii]  10.1038/eye.2008.84 PubMedCrossRefGoogle Scholar
  47. Lewis H, Abrams GW, Williams GA (1987) Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol 104(6):607–613PubMedGoogle Scholar
  48. Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99(5):753–759PubMedGoogle Scholar
  49. Liggett PE, Lean JS, Barlow WE, Ryan SJ (1987) Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy. Am J Ophthalmol 103(2):146–149PubMedGoogle Scholar
  50. Mandelcorn MS, Blankenship G, Machemer R (1976) Pars plana vitrectomy for the management of sever diabetic retinopathy. Am J Ophthalmol 81(5):561–570PubMedGoogle Scholar
  51. Mason JO III, Colagross CT, Haleman T, Fuller JJ, White MF, Feist RM, Emond TL, McGwin G Jr (2005) Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy. Am J Ophthalmol 140(2):231–235PubMedCrossRefGoogle Scholar
  52. Micelli FT, Cardascia N, Durante G, Vetrugno M, Cardia L (1999) Pars plana vitrectomy in diabetic macular edema. Doc Ophthalmol 97(3–4):471–474CrossRefGoogle Scholar
  53. Michels RG (1978) Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol 96(2):237–246PubMedCrossRefGoogle Scholar
  54. Miki A, Oshima Y, Otori Y, Kamei M, Tano Y (2008) Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma. Br J Ophthalmol 92(10):1431–1433. doi: 92/10/1431, [pii]  10.1136/bjo.2007.129833 PubMedCrossRefGoogle Scholar
  55. Morse LS, Chapman CB, Eliott D, Benner JD, Blumenkranz MS, McCuen BW (1997) Subretinal hemorrhages in proliferative diabetic retinopathy. Retina 17(2):87–93PubMedCrossRefGoogle Scholar
  56. Novak MA, Rice TA, Michels RG, Auer C (1984) Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology 91(12):1485–1489PubMedGoogle Scholar
  57. Oldendoerp J, Spitznas M (1989) Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus. Graefes Arch Clin Exp Ophthalmol 227(1):1–8PubMedCrossRefGoogle Scholar
  58. Otani T, Kishi S (2002) A controlled study of vitrectomy for diabetic macular edema. Am J Ophthalmol 134(2):214–219PubMedCrossRefGoogle Scholar
  59. Oyakawa RT, Schachat AP, Michels RG, Rice TA (1983) Complications of vitreous surgery for diabetic retinopathy. I. Intraoperative complications. Ophthalmology 90(5):517–521PubMedGoogle Scholar
  60. Park JH, Woo SJ, Ha YJ, Yu HG (2009) Effect of vitrectomy on macular microcirculation in patients with diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 247(8):1009–1017. doi: 10.1007/s00417-009-1062-1 PubMedCrossRefGoogle Scholar
  61. Pearson RV, McLeod D, Gregor ZJ (1993) Removal of silicone oil following diabetic vitrectomy. Br J Ophthalmol 77(4):204–207PubMedCrossRefGoogle Scholar
  62. Pendergast SD, Martin DF, Proia AD, Jaffe GJ, McCuen BW (1995) Removal of optic disc stalks during diabetic vitrectomy. Retina 15(1):25–28PubMedCrossRefGoogle Scholar
  63. Pendergast SD, Hassan TS, Williams GA, Cox MS, Margherio RR, Ferrone PJ, Garretson BR, Trese MT (2000) Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 130(2):178–186PubMedCrossRefGoogle Scholar
  64. Ramulu PY, Do DV, Corcoran KJ, Corcoran SL, Robin AL (2010) Use of retinal procedures in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol 128(10):1335–1340. doi: 128/10/1335, [pii]  10.1001/archophthalmol.2010.224 PubMedCrossRefGoogle Scholar
  65. Rice TA, Michels RG, Rice EF (1983a) Vitrectomy for diabetic rhegmatogenous retinal detachment. Am J Ophthalmol 95(1):34–44PubMedGoogle Scholar
  66. Rice TA, Michels RG, Rice EF (1983b) Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol 95(1):22–33PubMedGoogle Scholar
  67. Rinkoff JS, De Juan E Jr, McCuen BW (1986) Silicone oil for retinal detachment with advanced proliferative vitreoretinopathy following failed vitrectomy for proliferative diabetic retinopathy. Am J Ophthalmol 101(2):181–186PubMedGoogle Scholar
  68. Romano MR, Gibran SK, Marticorena J, Wong D, Heimann H (2008) Can a preoperative bevacizumab injection prevent recurrent postvitrectomy diabetic vitreous haemorrhage? Eye. doi: eye2008354, [pii]  10.1038/eye.2008.354
  69. Sakamoto T, Fujisawa K, Kinukawa N, Ishibashi T, Inomata H (2002) Re-worsening factor after successful vitrectomy for diabetic retinopathy: optic disc fibrovascular proliferation and macular disease. Ophthalmologica 216(2):101–107PubMedCrossRefGoogle Scholar
  70. Sakuraba T, Suzuki Y, Mizutani H, Nakazawa M (2000) Visual improvement after removal of submacular exudates in patients with diabetic maculopathy. Ophthalmic Surg Lasers 31(4):287–291PubMedGoogle Scholar
  71. Sato Y, Lee Z, Shimada H (2002) Vitrectomy for diabetic cystoid ­macular edema. Jpn J Ophthalmol 46(3):315–322PubMedCrossRefGoogle Scholar
  72. Sawa H, Ikeda T, Matsumoto Y, Niiya A, Kinoshita S (2000) Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy. Jpn J Ophthalmol 44(2):154–160PubMedCrossRefGoogle Scholar
  73. Schwatz SD, Alexander R, Hiscott P, Gregor ZJ (1996) Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology 103(2):323–328PubMedGoogle Scholar
  74. Scuderi JJ, Blumenkranz MS, Blankenship G (1982) Regression of diabetic rubeosis iridis following successful surgical reattachment of the retina by vitrectomy. Retina 2(4):193–196PubMedCrossRefGoogle Scholar
  75. Singh RP, Margolis R, Kaiser PK (2007) Cystoid puncture for chronic cystoid macular oedema. Br J Ophthalmol 91(8):1062–1064. doi: bjo.2006.101790, [pii]  10.1136/bjo.2006.101790 PubMedCrossRefGoogle Scholar
  76. Steel DH, Habib MS, Park S, Hildreth AJ, Owen RI (2008) Entry site neovascularization and vitreous cavity hemorrhage after dia-betic vitrectomy. The predictive value of inner sclerostomy site ultrasonography. Ophthalmology 115(3):525–532. doi: S0161-6420(07)00938-4, [pii]  10.1016/j.ophtha.2007.08.034 PubMedCrossRefGoogle Scholar
  77. Steinmetz RL, Grizzard WS, Hammer ME (2002) Vitrectomy for diabetic traction retinal detachment using the multiport illumination system. Ophthalmology 109(12):2303–2307PubMedCrossRefGoogle Scholar
  78. Summanen P, Karhunen U, Laatikainen L (1987) Characteristics and survival of diabetic patients undergoing vitreous surgery. Acta Ophthalmol (Copenh) 65(2):197–202CrossRefGoogle Scholar
  79. Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122(2):258–260PubMedGoogle Scholar
  80. Takagi H, Otani A, Kiryu J, Ogura Y (1999) New surgical approach for removing massive foveal hard exudates in diabetic macular edema. Ophthalmology 106(2):249–256PubMedCrossRefGoogle Scholar
  81. The Diabetic Retinopathy Study Research Group (1978) Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 85(1):82–106Google Scholar
  82. The Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathyClinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 88(7):583–600Google Scholar
  83. The Diabetic Retinopathy Vitrectomy Study Research Group (1985) Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy Two-year results of a randomized trial Diabetic Retinopathy Vitrectomy Study report 2. ArchOphthalmol 103(11):1644–1652Google Scholar
  84. The Diabetic Retinopathy Vitrectomy Study Research Group (1988) Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision Results of a randomized trial–Diabetic Retinopathy Vitrectomy Study Report 3. Ophthalmology 95(10):1307–1320Google Scholar
  85. Thomas D, Bunce C, Moorman C, Laidlaw DA (2005) A randomised controlled feasibility trial of vitrectomy versus laser for diabetic macular oedema. Br J Ophthalmol 89(1):81–86. doi: 89/1/81, [pii]  10.1136/bjo.2004.044966 PubMedCrossRefGoogle Scholar
  86. Tolentino FI, Cajita VN, Gancayco T, Skates S (1989) Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy. Ophthalmology 96(10):1495–1500PubMedGoogle Scholar
  87. Tong L, Vernon SA, Kiel W, Sung V, Orr GM (2001) Association of macular involvement with proliferative retinopathy in type 2 diabetes. Diabet Med 18(5):388–394PubMedCrossRefGoogle Scholar
  88. Ulbig MW, Mangouritsas G, Rothbacher HH, Hamilton AM, McHugh JD (1998) Long-term results after drainage of premacular ­subhyaloid hemorrhage into the vitreous with a pulsed Nd:YAG laser. Arch Ophthalmol 116(11):1465–1469PubMedCrossRefGoogle Scholar
  89. Virata SR, Kylstra JA (2001) Postoperative complications following vitrectomy for proliferative diabetic retinopathy with sew-on and noncontact wide-angle viewing lenses. Ophthalmic Surg Lasers 32(3):193–197PubMedGoogle Scholar
  90. Wand M, Madigan JC, Gaudio AR, Sorokanich S (1990) Neovascular glaucoma following pars plana vitrectomy for complications of diabetic retinopathy. Ophthalmic Surg 21(2):113–118PubMedGoogle Scholar
  91. West JF, Gregor ZJ (2000) Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol 84(8):822–825PubMedCrossRefGoogle Scholar
  92. Williams DF, Williams GA, Hartz A, Mieler WF, Abrams GW, Aaberg TM (1989) Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique. Ophthalmology 96(6):752–758PubMedGoogle Scholar
  93. Wilson-Holt N, Gregor Z (1992) Spontaneous relieving retinotomies in diabetic silicone filled eyes. Eye 6(Pt 5):461–464PubMedCrossRefGoogle Scholar
  94. Yamamoto T, Hitani K, Tsukahara I, Yamamoto S, Kawasaki R, Yamashita H, Takeuchi S (2003) Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol 135(1):14–19PubMedCrossRefGoogle Scholar
  95. Yang CM (2000) Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina 20(2):121–125PubMedCrossRefGoogle Scholar
  96. Yang CM, Yeh PT, Yang CH (2007) Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Ophthalmology 114(4):710–715. doi: S0161-6420(06)01157-2, [pii]  10.1016/j.ophtha.2006.07.047 PubMedCrossRefGoogle Scholar
  97. Yang CM, Yeh PT, Yang CH, Chen MS (2008) Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol 146(2):211–217. doi: S0002-9394(08)00312-7, [pii]  10.1016/j.ajo.2008.04.028 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Thomas H. Williamson
    • 1
  1. 1.Department of OphthalmologySt. Thomas’ HospitalLondonUK

Personalised recommendations

Cite chapter

Buy options